Your browser doesn't support javascript.
loading
MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL.
Improgo, Ma Reina; Tesar, Bethany; Klitgaard, Josephine L; Magori-Cohen, Reuma; Yu, Lijian; Kasar, Siddha; Chaudhary, Divya; Miao, Wenyan; Fernandes, Stacey M; Hoang, Kevin; Westlin, William F; Kim, Haesook T; Brown, Jennifer R.
Affiliation
  • Improgo MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Cambridge, MA, USA.
  • Tesar B; Department of Medicine, Harvard Medical School, Cambridge, MA, USA.
  • Klitgaard JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Cambridge, MA, USA.
  • Magori-Cohen R; Department of Medicine, Harvard Medical School, Cambridge, MA, USA.
  • Yu L; Department of Medical Oncology, Dana-Farber Cancer Institute, Cambridge, MA, USA.
  • Kasar S; Department of Medicine, Harvard Medical School, Cambridge, MA, USA.
  • Chaudhary D; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Cambridge, MA, USA.
  • Miao W; Department of Biostatistics, Harvard School of Public Health, Cambridge, MA, USA.
  • Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Cambridge, MA, USA.
  • Hoang K; Department of Medicine, Harvard Medical School, Cambridge, MA, USA.
  • Westlin WF; Department of Medical Oncology, Dana-Farber Cancer Institute, Cambridge, MA, USA.
  • Kim HT; Department of Medicine, Harvard Medical School, Cambridge, MA, USA.
  • Brown JR; Nimbus Therapeutics, Inc., Cambridge, MA, USA.
Br J Haematol ; 184(6): 925-936, 2019 03.
Article de En | MEDLINE | ID: mdl-30537114
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie chronique lymphocytaire à cellules B / Facteur de différenciation myéloïde-88 Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Br J Haematol Année: 2019 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie chronique lymphocytaire à cellules B / Facteur de différenciation myéloïde-88 Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Br J Haematol Année: 2019 Type de document: Article Pays d'affiliation: États-Unis d'Amérique